fulvestrant has been researched along with Myocardial Ischemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Korzick, DH; Lancaster, TS; Novotny, JL; Simpson, AM; Tomicek, NJ | 1 |
Booth, EA; Kilbourne, EJ; Knittel, AK; Lucchesi, BR; Marchesi, M | 1 |
2 other study(ies) available for fulvestrant and Myocardial Ischemia
Article | Year |
---|---|
Rapid estrogen receptor-alpha activation improves ischemic tolerance in aged female rats through a novel protein kinase C epsilon-dependent mechanism.
Topics: Adaptation, Physiological; Aging; Animals; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Myocardial Reperfusion Injury; Ovariectomy; Phenols; Postmenopause; Protein Kinase C-epsilon; Pyrazoles; Rats; Rats, Inbred F344; Signal Transduction; Time Factors; Tissue Distribution | 2009 |
The pathway-selective estrogen receptor ligand WAY-169916 reduces infarct size after myocardial ischemia and reperfusion by an estrogen receptor dependent mechanism.
Topics: Animals; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Ligands; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Ovariectomy; Pyrazoles; Rabbits; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2007 |